JeffreyLorenzNeulMDPh.D.

Director, Vanderbilt Kennedy Center

Dr. Neul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Baylor College of MedicineResidency, Child Neurology, 2000 - 2005
Baylor College of MedicineFellowship, Child Neurology, 2001 - 2004
Baylor College of MedicineInternship, Transitional Year, 2000 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000

TN State Medical License 2018 - 2025
TX State Medical License 2006 - 2025
CA State Medical License 2014 - 2022
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Circle of Angels award for dedication to research on Rett syndrome International Rett Syndrome Foundation, 2011
Philip R. Dodge Young Investigator Award Child Neurology Society, 2009

PubMed

MECP2 Variants in Males: More Common than Previously Appreciated.
Amitha Ananth, Cary Fu, Jeffrey L Neul, Tim Benke, Eric Marsh
Pediatric Neurology. 2024-12-01
Modeling antisense oligonucleotide therapy in MECP2 duplication syndrome human iPSC-derived neurons reveals gene expression programs responsive to MeCP2 levels.
Sameer S Bajikar, Yehezkel Sztainberg, Alexander J Trostle, Harini P Tirumala, Ying-Wooi Wan
Human Molecular Genetics. 2024-11-08
Testing the PEST hypothesis using relevant Rett mutations in MeCP2 E1 and E2 isoforms.
Ladan Kalani, Bo-Hyun Kim, Alberto Ruiz de Chavez, Anastasia Roemer, Anna Mikhailov
Human Molecular Genetics. 2024-11-05

First Treatment Approved for Rare Genetic Neurologic DisorderMarch 13th, 2023
Acadia Pharmaceuticals Announces U.S. FDA Approval of DAYBUE™ (Trofinetide) for the Treatment of Rett Syndrome in Adult and Pediatric Patients Two Years of Age and OlderMarch 11th, 2023
Trofinetide Shows Promise in Rett SyndromeApril 6th, 2022
Join now to see all

Rett Syndrome, MECP2 Duplications, and Rett-related Disorders Natural HistoryEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2014–Present
Baylor Intellectual and Developmental Disabilities Research CentersEEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2014–Present
Identification of Genetic Modifiers in Rett Syndrome.Rett Syndrome Research Trust2013–Present
NNZ-2566 in Adult Rett SyndromeNeuren Pharmaceuticals2012–Present
A randomized, double-blind placebo controlled trial of NNZ-2566 (IGF-1{1-3}, glycyl-L-2-methylprolyl-L-glutamine acid) with open label extension in adults with Rett syndromeInternational Rett Syndrome Foundation2012–Present
Nonsense suppression as a therapeutic approach to Rett syndromeInternational Rett Syndrome Foundation2012–Present
Creation of a DNA repository for Rett syndromeInternational Rett Syndrome Foundation2012–2014
Characterization Of Autonomic Dysfunction In Rett Syndrome And Other MECP2 DisordEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
Analysis Of The Dopamine System In Rett SyndromeNational Institute Of Neurological Disorders And Stroke2005–2009